Danny Galbraith - head of New Services and Technology Management at Merck KGaA, Darmstadt, Germany, explores the innovation bringing RNA Therapeutics to the clinic.
Fernando Geijo and Xavier Ruiz, manager of QA for R&D and QRD auditor, respectively, at Azbil Telstar discuss the importance of adopting good practices in clinical research.
EPM speaks to Rafael Teixeira, President of logistics suppliers World Courier and ICS about the challenges of distributing a Covid-19 vaccine after approval.
This In Conversation feature sees Dr Thomas Kofoed co-founder of Alphalyse speaking to Mani Krishnan, VP/GM of SCIEX about the work the company is doing to help improve biologic drug development.
EPM editor Reece Armstrong sits down with Panna Sharma, CEO of Lantern Pharma to discuss what an Initial Public Offering of $27 million means for the company and where this biopharma is headed next.
Angelo Giambrone - business development manager at Spirax Sarco UK discusses the steps pharmaceutical managers can take to improve steam system efficiency, maximise process and final product quality, and optimise overall productivity.
Isabel Losantos, senior consultant - Design Assurance, at Cambridge Consultants and Joe Corrigan, head of Medical Technology examine the potential AI represents in life sciences and the regulatory changes it brings.
Penny Pinnock, sales manager – Healthcare & Public Sector for Siemens Financial Services (SFS) discusses why NHS trusts must work together to meet the challenges facing their laboratories.
EPM speaks to Paul Burden, chief commercial officer – Strategic Growth, at ADVANZ PHARMA about niche medicines, the challenges of working with multiple partners and why competition is everywhere in pharma.
